Contribution of Serum Biomarkers to Prognostic Assessment in Patients With Oligometastatic Prostate Cancer
Sign Up to like & getrecommendations! Published in 2019 at "In Vivo"
DOI: 10.21873/invivo.11495
Abstract: Background/Aim: The aim of this study was to analyze the prognostic impact of biomarkers, such as serum lactate dehydrogenase (LDH), in patients with oligometastatic castration-resistant prostate cancer, arbitrarily defined as a maximum of five metastatic… read more here.
Keywords: contribution serum; biomarkers prognostic; serum biomarkers; prostate cancer ... See more keywords